当前位置：
主页产品
详情

N-[(1S)-1-[(3-Chlorophenyl)methyl]-2-[(cyanomethyl)amino]-2-oxoethyl]-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide | CAS:225120-65-0

N-[(1S)-1-[(3-Chlorophenyl)methyl]-2-[(cyanomethyl)amino]-2-oxoethyl]-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide

名称：N-[(1S)-1-[(3-氯苯基)甲基]-2-[(氰基甲基)氨基]-2-氧代乙基]-3-叔丁基-1-甲基-1H-吡唑-5-甲酰胺 | N-[(1S)-1-[(3-Chlorophenyl)methyl]-2-[(cyanomethyl)amino]-2-oxoethyl]-3-(1,1-dimethylethyl)-1-methyl-1H-pyrazole-5-carboxamide
CAS号：225120-65-0
别名：
分子式：C₂₀H₂₄ClN₅O₂
分子量：401.89
EINESC号：

产品描述

物理化学性质

密度	1.23±0.1 g/cm3 (20 ºC

安全数据

没有数据	没有数据

SDS

来源	SDS样本
没有数据	没有数据

产品合成路线

名称	CAS号

文章

同行评议文献

Neonatal Consumption of Oligosaccharides Greatly Increases L-Cell Density without Significant Consequence for Adult Eating Behavior.Gwenola Le Dréan et al.Nutrients, 11(9) (2019-08-24) Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.Sha Liu et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 96, 132-142 (2015-07-30) Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.Helena Montanuy et al.Clinical cancer research : an official journal of the American Association for Cancer Research, 26(12), 3044-3057 (2020-02-02) Continuous Processing of Active Pharmaceutical Ingredients Suspensions via Dynamic Cross-Flow Filtration.Johannes Gursch et al.Journal of pharmaceutical sciences, 104(10), 3481-3489 (2015-07-07)

备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称	CAS号

产品描述

物理化学性质

安全数据

SDS

相关产品

相关资讯